NASDAQ: ARTV
Artiva Biotherapeutics Inc Stock Ownership - Who owns Artiva Biotherapeutics?

Insider buying vs selling

Have Artiva Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ra Capital Management LPDirector2026-07-3124,944$9.93
$247.69kBuy
Ra Capital Management LPDirector2026-07-2920,824$9.99
$208.03kBuy
Ra Capital Management LPDirector2026-07-2441,319$9.99
$412.78kBuy
Ra Capital Management LPDirector2026-07-2359,880$9.96
$596.40kBuy
Ra Capital Management LPDirector2026-07-2284,124$9.93
$835.35kBuy
Ra Capital Management LPDirector2026-07-177,882$8.95
$70.54kBuy
Ra Capital Management LPDirector2026-07-16152,472$8.93
$1.36MBuy
Ra Capital Management LPDirector2026-07-136,522$8.94
$58.31kBuy
Ra Capital Management LPDirector2026-07-136,552$8.94
$58.57kBuy
Ra Capital Management LPDirector2026-07-1015,102$8.97
$135.46kBuy

1 of 5

ARTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARTV insiders and whales buy or sell their stock.

ARTV Shareholders

What type of owners hold Artiva Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP39.87%9,853,302$102.77MInstitution
Gc Corp24.27%5,999,703$62.58MInsider
Yongjun Huh19.89%4,916,249$51.28MInsider
5am Partners VI LLC9.52%2,353,304$24.54MInsider
5am Venture Management LLC9.52%2,353,304$24.54MInstitution
Venbio Global Strategic Fund III LP7.84%1,936,637$20.20MInsider
Venrock Adviser LLC6.51%1,609,569$16.79MInstitution
Fred Aslan6.21%1,535,082$16.01MInsider
Venbio Partners LLC2.15%531,337$5.54MInstitution
Franklin Resources Inc2.11%520,327$5.43MInstitution

1 of 3

ARTV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTV47.68%52.32%Net BuyingNet Buying
TTRX1.55%58.04%Net Buying
VRXA9.92%8.95%
EDIT52.94%33.63%Net SellingNet Selling
AVXL43.15%4.79%Net Buying

Artiva Biotherapeutics Stock Ownership FAQ

Who owns Artiva Biotherapeutics?

Artiva Biotherapeutics (NASDAQ: ARTV) is owned by 68.11% institutional shareholders, 74.74% Artiva Biotherapeutics insiders, and 0.00% retail investors. Gc Corp is the largest individual Artiva Biotherapeutics shareholder, owning 6.00M shares representing 24.27% of the company. Gc Corp's Artiva Biotherapeutics shares are currently valued at $60.60M.

If you're new to stock investing, here's how to buy Artiva Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.